Varian Medical Systems selected for new proton therapy centre
Mannheimer Swartling has assisted Varian Medical Systems in entering into agreements for delivery of a proton therapy system to Skandionkliniken. The agreements include supply of an estimated USD 60 million in products. Varian Medical Systems will also have a five year service agreement valued at approximately USD 25 million. Skandionkliniken is the first clinical centre for proton therapy in Scandinavia and will have a capacity of treating 1,000 – 2,500 cancer patients per year. Varian Medical Systems is the world’s leading manufacturer of medical devices and software for treating cancer.
Mannheimer Swartling’s team was led by Bo Söderberg and Klas Wennström who were assisted mainly by Frida Fexler and Ola Ihse.